MART-1:27-35 peptide vaccine

Definition / meaning of MART-1:27-35 peptide vaccine

A natural or synthetic peptide cancer vaccine consisting of amino acid residues 27 through 35 of the melanoma-associated antigen MART-1 with potential antineoplastic activity. Vaccination with MART-1:27-35 peptide may induce cytotoxic host immune responses against melanoma cells that express this peptide.

Listed under:

Find More About 'MART-1:27-35 peptide vaccine'


The Web site of the National Cancer Institute (

Leave a Comment


This site uses Akismet to reduce spam. Learn how your comment data is processed.